Please Note:

The Open Access Repository will be moving to a new authentication system on the 1st of November.

From this date onwards, account holders will be required to login using their University of Tasmania credentials.
If your current repository username differs from your University username, please email E.Prints@utas.edu.au so we can update these details on your behalf.

Due to the change, there will be a short outage of the repository from 9am on the morning of the 1st of November

Open Access Repository

A role for the tissue factor pathway in the pathogenesis of the antiphospholipid syndrome

Downloads

Downloads per month over past year

Lean, SY and Adams, MJ (2007) A role for the tissue factor pathway in the pathogenesis of the antiphospholipid syndrome. Australian Journal of Medical Science, 28 (3). pp. 99-107. ISSN 1038-1643

[img] PDF
Adams_and_Lean_...pdf | Request a copy
Full text restricted
Available under University of Tasmania Standard License.

Abstract

The antiphospholipid syndrome (aPS) is a systemic autoimmune disorder that is characterised by
laboratory markers of antiphospholipid antibodies (aPL) as well as clinical manifestations such as arterial
and venous thrombosis, recurrent pregnancy loss and thrombocytopaenia. Although it is unclear precisely
what mechanism(s) lead to thrombosis in aPS, it is probable that the contribution of aPL such as anti-β-2-
glycoprotein-1 (anti-β2GP1) is signifi cant. Indeed, there is increasing evidence that aPL may interfere with
the tissue factor (TF) pathway of blood coagulation and its natural regulator tissue factor pathway inhibitor
(TFPI), thus contributing toward the development of thrombosis in aPS. This paper will therefore review
1) the TF pathway of blood coagulation and TFPI, 2) clinical and laboratory aspects of aPL and aPS,
and 3) interactions of aPL with the TF pathway, to highlight the potential signifi cance of these in the
pathogenesis of aPS.

Item Type: Article
Keywords: Antiphospholipid antibodies; Antiphospholipid syndrome; Thrombosis; Tissue factor; Tissue factor pathway inhibitor
Journal or Publication Title: Australian Journal of Medical Science
Page Range: pp. 99-107
ISSN: 1038-1643
Date Deposited: 15 Nov 2007 01:28
Last Modified: 18 Nov 2014 03:24
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP